Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-06-17FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SEROQUEL XR (quetiapine) from AstraZeneca Pharmaceuticals LP. This action modifies the product l…
-
FDA approval · 2016-06-10FDA Approved: PAROXETINE — Original Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's original ANDA for paroxetine (paroxetine hydrochloride), establishing a generic version of the antidepr…
-
FDA approval · 2016-05-17FDA Approved: QUETIAPINE FUMARATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for a generic version of quetiapine fumarate by Macleods Pharmaceuticals Limited.
-
FDA approval · 2016-05-05FDA Approved: DESIPRAMINE HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an Original Application for desipramine hydrochloride, a generic antidepressant product from Heritage Pharmaceuticals (Avet). T…
-
FDA approval · 2016-04-25FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for WELLBUTRIN SR (bupropion hydrochloride) submitted by GlaxoSmithKline LLC. The action confirms th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-04-25FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for amitriptyline hydrochloride by Aurobindo Pharma Limited.
-
FDA approval · 2016-04-25FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE (Mylan Pharmaceuticals Inc.). This action updates t…
-
FDA approval · 2016-04-25FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Amitriptyline hydrochloride by Sandoz Inc, indicating approval of changes to the existing generi…
-
FDA approval · 2016-04-15FDA Approved: TRIMIPRAMINE — Original Application (Breckenridge Pharmaceutical, Inc.)
The FDA approved Breckenridge Pharmaceutical's original application for trimipramine, a generic antidepressant.
-
FDA approval · 2016-03-31FDA Approved: ESCITALOPRAM — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for escitalopram from Macleods Pharmaceuticals Limited (generic escitalopram).
-
FDA approval · 2016-03-23FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for escitalopram oxalate from Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2016-03-17FDA Approved: DESIPRAMINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's desipramine hydrochloride as a generic product through an original ANDA. Desipramine is used to…
-
FDA approval · 2016-03-16FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application to add an extended-release formulation of desvenlafaxine succinate (Pristiq Extended-Release) by…
-
FDA approval · 2016-03-14FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for sertraline hydrochloride from Aurobindo Pharma Limited, enabling the commercialization of a gene…
-
FDA approval · 2016-03-14FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
The FDA approved a supplemental application from Quallent Pharmaceuticals Health LLC to market fluoxetine hydrochloride as a generic product…
-
FDA approval · 2016-03-08FDA Approved: QUETIAPINE FUMARATE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved Quetiapine Fumarate as a generic tablet under Original Application (ANDA 202674) for Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2016-03-01FDA Approved: BUPROPION HYDROCHLORIDE SR — Original Application (Dr. Reddys Laboratories Inc.)
FDA approved Dr. Reddy's Laboratories' generic version of bupropion hydrochloride sustained-release (SR) under an Original Application (ANDA…
-
FDA approval · 2016-02-29FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2016-02-16FDA Approved: DESVENLAFAXINE — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved the original ANDA for desvenlafaxine submitted by Hikma Pharmaceuticals USA Inc., providing a generic option for this antid…
-
FDA approval · 2016-02-09FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Original Application (Cipla USA Inc.,)
The FDA approves Cipla USA Inc.'s original application for a generic sustained-release formulation of bupropion hydrochloride (SR).
-
FDA approval · 2016-02-02FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for imipramine hydrochloride (ANDA 090441), a generic antidepressant.
-
FDA approval · 2016-02-02FDA Approved: IMIPRAMINE PAMOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc)
The FDA approved a supplemental application for Imipramine Pamoate by Hikma Pharmaceuticals USA Inc, indicating an approved change to an exi…
-
FDA approval · 2016-02-02FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Camber Pharmaceuticals to offer escitalopram oxalate as a generic antidepressant, expanding …
-
FDA approval · 2016-01-28FDA Approved: LEXAPRO — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Lexapro (escitalopram) by Allergan, Inc. The action updates the product labeling per the approve…
-
FDA approval · 2016-01-26FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for venlafaxine hydrochloride from Aurobindo Pharma Limited.